Treatment of cholangiocarcinoma

By | May 5, 2012

Treatment of cholangiocarcinoma, bile duct cancer patients, the preferred treatment is surgical excision. When a patient by the B-, CT, PTC, ERCP can not be checked or surgical exploration should be removed when the following treatment:
(1) can not be radical resection of the tumor, but still capable of excision, should seek palliative tumor resection, postoperative radiotherapy and chemotherapy, can further improve the curative effect and improve the patients quality of life.
(2) radiation therapy: Cholangiocarcinoma is not sensitive to radiotherapy, radical treatment can not achieve the purpose. Patients with advanced cholangiocarcinoma palliative radiotherapy, local tumor ulceration can to alleviate the obstruction of the state to ease the symptoms.
Currently, the main application is in vitro exposure to F body brachytherapy: the use of radioisotopes in the bile duct within a four-exposure, to achieve the purpose of treatment. Direct exposure to radiation tumor, less damage to normal tissue.
(3) for unresectable advanced cases, can be implemented palliative biliary drainage to relieve obstruction, reduce the yellow disease, biliary tract infection control, improve liver function and prolong the patient's life.
(4) chemotherapy: Currently, chemotherapy for bile duct cancer drugs Gemzar, Xeloda and so on, but the tumor is often wrapped connective tissue, blood supply is poor, so poor effect of chemotherapy, and 1 / 3 of patients a response to chemotherapy.
Treatment for cholangiocarcinoma, (5) Intervention: PTCD and biliary stent placement: for preoperative jaundice, and patients with advanced inoperable drainage, aims to improve the liver to reduce liver damage, relieve symptoms and prolong life.

Leave a Reply

Your email address will not be published. Required fields are marked *